These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 182114

  • 21. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A, Passemard F, Perdu D, Vallerand H, Deschamps F, Lavaud F, Larbre H.
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [Abstract] [Full Text] [Related]

  • 22. Elastin metabolism parameters in sera of patients with lung cancer.
    Gmiński J, Mykala-Cieśla J, Machalski M, Drózdz M.
    Neoplasma; 1993; 40(1):41-4. PubMed ID: 8394514
    [Abstract] [Full Text] [Related]

  • 23. Infrequent elevation of plasma ACTH in patients with bronchogenic carcinoma.
    Davis S, May PB.
    Am J Med Sci; 1982; 283(1):2-7. PubMed ID: 6275702
    [Abstract] [Full Text] [Related]

  • 24. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
    Cha RJ, Chen SJ, Xiao CZ, Liang XL, Zhou NK.
    Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
    [Abstract] [Full Text] [Related]

  • 25. [Blood levels of alpha 1- antitrypsin in pulmonary neoplasms].
    Galietti F, Tartaglino B, Ferrua M, Ardizzi A, Barberis S.
    Arch Sci Med (Torino); 1981 Sep; 138(4):497-9. PubMed ID: 6280642
    [No Abstract] [Full Text] [Related]

  • 26. [Beta-2-microglobulin in bronchogenic carcinoma].
    Zatloukal P, Dudková V, Mĕricka O.
    Sb Lek; 1990 Sep; 92(11-12):366-9. PubMed ID: 2136432
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
    Becker KL, Snider RH, Silva OL, Moore CF.
    Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Relation between serum neuron-specific enolase and CEA levels in the patients with lung cancer].
    Hou LP.
    Zhonghua Jie He He Hu Xi Za Zhi; 1988 Aug; 11(4):219-21, 255. PubMed ID: 2852546
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Biomarkers and IL-2R in lung cancer.
    Marino P, Preatoni A, Fonticoli L, Parodi M, Tarolo GL.
    Recenti Prog Med; 1990 Nov; 81(11):702-4. PubMed ID: 1962891
    [Abstract] [Full Text] [Related]

  • 39. [Significance of factors of coagulation and fibrinolysis in progression of lung cancer].
    Nagayama M, Tachibana A, Hayakawa H, Sato A.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):180-5. PubMed ID: 8390588
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.